Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (otvara novi prozor)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Izvor‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Indeks‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (otvara novi prozor)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (otvara novi prozor)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Izvor‎: Cochrane Database Syst Rev 2018;4:CD011689.

Indeks‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (otvara novi prozor)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (otvara novi prozor)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Izvor‎: Am J Obstet Gynecol.

Indeks‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (otvara novi prozor)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (otvara novi prozor)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Izvor‎: S Afr Med J 2016;106(4):399-402.

Indeks‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (otvara novi prozor)

Prophylactic use of ergot alkaloids in the third stage of labour. (otvara novi prozor)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Izvor‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Indeks‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (otvara novi prozor)

Treatment for primary postpartum haemorrhage. (otvara novi prozor)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Izvor‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Indeks‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (otvara novi prozor)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (otvara novi prozor)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Izvor‎: Obstet Gynecol 2001;98(3):386-90.

Indeks‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (otvara novi prozor)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (otvara novi prozor)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Izvor‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Indeks‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (otvara novi prozor)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (otvara novi prozor)

Ragab A, Barakat R, Alsammani MA.

Izvor‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Indeks‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (otvara novi prozor)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (otvara novi prozor)

Roach MK, Abramovici A, Tita AT.

Izvor‎: Am J Perinatol 2013;30(7):523-8.

Indeks‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (otvara novi prozor)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (otvara novi prozor)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Izvor‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Indeks‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (otvara novi prozor)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (otvara novi prozor)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Izvor‎: Lancet Glob Health. 2023 11(2):e287-e295.

Indeks‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (otvara novi prozor)

Intravenous sulprostone infusion in the treatment of retained placenta. (otvara novi prozor)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Izvor‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Indeks‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (otvara novi prozor)

Carbetocin for preventing postpartum haemorrhage. (otvara novi prozor)

Su LL, Chong YS, Samuel M.

Izvor‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Indeks‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (otvara novi prozor)

Prostaglandins for preventing postpartum haemorrhage. (otvara novi prozor)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Izvor‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Indeks‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (otvara novi prozor)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (otvara novi prozor)

Westhoff G, Cotter AM, Tolosa JE.

Izvor‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Indeks‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (otvara novi prozor)